Tech Company Financing Transactions
Auspex Pharmaceuticals Funding Round
Auspex Pharmaceuticals closed a funding round on 3/12/2013. Investors included Square 1 Bank.
Transaction Overview
Company Name
Announced On
3/12/2013
Transaction Type
Debt
Amount
Unknown
Round
Undisclosed
Investors
Square 1 Bank (Scott Foote)
Proceeds Purpose
Proceeds will be used to supplement working capital while entering Phase 3 clinical trials for its leading compound SD-809.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
3366 North Torrey Pines Ct. 225
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
Auspex Pharmaceuticals is a developer of next-generation medicines with improved safety and performance and a pioneer in the targeted application of deuterium chemistry to clinically validated drugs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Pratik Shah
Chief Financial Officer
John Schmid
Chief Medical Officer
David Stamler
Chief Operating Officer
Bharatt Chowrira
Chief Operating Officer
Andreas Sommer
Browse more venture capital transactions:
Prev: 3/12/2013: Evolv venture capital transaction
Next: 3/12/2013: Lyft venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs